NewLink Genetics Corp
Change company Symbol lookup
Select an option...
NLNK NewLink Genetics Corp
SFDPF Spark Infrastructure Group
SEDO Seedo Corp
SBRKF Sparebank 1 SR Bank ASA
SBBZF Soilbuild Business Space REIT
SAVE Spirit Airlines Inc
SAPMY Saipem SpA
SAPMF Saipem SpA
SANM Sanmina Corp
SAFLY Safilo Group SpA
Go

Health Care : Biotechnology | Small Cap ValueCompany profile

NewLink Genetics Corporation is a clinical-stage immuno-oncology company focused on discovering, developing and commercializing immunotherapeutic products for the treatment of cancer. The Company's portfolio includes biologic and small-molecule immunotherapy product candidates for a range of oncology indications. Its biologic product candidates are based on its HyperAcute Cellular Immunotherapy technology, which is designed to stimulate the human immune system to attack cancer cells. Its additional HyperAcute Cellular Immunotherapy product candidates in clinical development include tergenpumatucel-L and dorgenmeltucel-L for patients with advanced lung cancer and melanoma, respectively. Additionally, it has two small-molecule product candidates in clinical development: GDC-0919 and indoximod. These product candidates are indoleamine-2, 3-dioxygenase (IDO) pathway inhibitors and focus on breaking the immune system's tolerance to cancer.

Closing Price
$1.63
Day's Change
0.025 (1.56%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.73
Day's Low
1.58
Volume
(Below Average)
Volume:
227,006

10-day average volume:
265,435
227,006

Verrency Appoints Dickson Chu to Global Advisory Board

7:30 am ET November 11, 2019 (BusinessWire) Print

Global payment innovation company Verrency today announced the appointment of Dickson Chu, an accomplished payments executive and business builder, to its global advisory board.

Mr. Chu has held leadership roles at prominent companies including Paypal, Wells Fargo, Yahoo!, Living Social and Citi, and is a board director and active advisor to a number of emerging payment companies. He is currently the head of BBVA's San Francisco office for New Digital Businesses, where he has overall BBVA group responsibility for the governance, budget and strategic direction of BBVA's growing global portfolio of Fintech businesses.

"Verrency is a truly unique company that has significant global momentum," said Mr. Chu. "Their innovative enabling platform can be deployed on top of existing payment infrastructure, offering a flexible, low-cost, and time efficient way for banks and financial institutions to improve their relationships with customers. They solve a global industry problem, and I'm excited to be joining Verrency where I can help David capitalise on the urgency amongst banks, processors and even super-apps to better compete for their customers around the moment of payment."

"Dickson's incredible fintech & payments experience, especially with financial institutions such as BBVA, PayPal and Citi are a tremendous asset as we look to expand the delivery of our patented API platform," said David Link, Verrency Founder and CEO. "Dickson's vision, passion and his depth of experience in precisely the area in which Verrency operates are invaluable as we continue our expansion across the United States and overseas. Dickson's unique insights will also be instrumental as Verrency continues to expand its service offerings into data analytics and other services around the moment of payment."

Verrency's industrial-grade platform fits on top of a bank's, processor's or wallet's existing infrastructure, opening the door for rapid delivery of enhanced features and new services without the need to change existing legacy technology or to migrate portfolios. The company has announced agreements with a number of major financial institutions around the world, including UAE-based Emirates NBD, Colombia's Banco Davivienda, Australia's Volt Bank, and the US-based global processor FIS, among others.

Prior to BBVA, Mr. Chu was Chief Product Officer and EVP Corporate Development at Ingo Money where he was responsible for strategy, product management, strategic alliances and M&A. Ingo Money focuses on transforming consumer access to money by increasing consumer adoption of new and existing digital payment platforms.

Mr. Chu also currently serves on the boards of Simple, Azlo, Covault, Denizen, Upturn, Ingo Money, Boomtown and Opportunity Fund.

About Verrency

Verrency puts financial institutions back at the centre of innovation. Verrency's payments innovation platform helps issuers to acquire and retain customers and increase payment spend while increasing security, control and connectability. Verrency works behind the scenes to enable an ever-increasing range of value-added services for an issuer's customers quickly and easily without major changes to existing payments infrastructure or the need to integrate to point-of-sale systems. Verrency also enables rapid connection to third-party services via its extensive FinTech ecosystem with little to no integration. For more information, see www.verrency.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20191111005270/en/

SOURCE: Verrency

Media 
Jonathan Costello
GRACosway
Jcostello@gracosway.com.au 
+61 424 096 770

Ron Low
Sard Verbinnen & Co
rlow@sardverb.com 
+852 3842 2200

Danya Al-Qattan
Sard Verbinnen & Co
Dal-Qattan@sardverb.com 
+1 212 687 8080

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.